Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome
In conclusion, testicular cancer patients with signs of hypogonadism presented with significantly increased risk of metabolic syndrome and investigation of endocrine and metabolic parameters is warranted in these patients.
Source: Andrology - Category: Urology & Nephrology Authors: C. Bogefors, S. Isaksson, J. Bobjer, M. Kitlinski, I. Leijonhufvud, K. Link, A. Giwercman Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Heart | Hormones | Insulin | Low Testosterone | Metabolic Syndrome | Statistics | Testicular Cancer | Urology & Nephrology